Becker's Healthcare October 15, 2019
A survey released Oct. 15 by healthcare legal and consulting group Mannat Health details how the 340B Drug Pricing Program works alongside Medicaid in all 50 states.
The survey shows how each state reimburses 340B covered entities, how states contract with pharmacies for 340B drugs and the steps states take to avoid duplicating discounts.
The survey found that 12 states rely solely on the Office of Pharmacy Affairs Medicaid Exclusion File to identify 340B drugs billed to the program to avoid duplicate discounts, while 22 states rely solely on claims-level identifiers and the other states rely on both.
One state prohibits all covered entities...
Today's Sponsors
Today's Sponsor